Bevastim
Bevastim is Bevacizumab, a monoclonal antibody against VEGF. It is indicated for multiple solid tumors including colorectal, lung, ovarian, and cervical cancers and works by inhibiting angiogenesis and thereby slowing tumor growth and spread.
Features
| Product Name | Bevastim |
| Generic Name | Bevacizumab |
| Formulation | Injectable |
| Available Pack Size | 1X1's |
| Available Strength | 100MG, 400MG |